Clinical Trials Browser

Phase 2 × Not yet recruiting × Adenocarcinoma of Lung × Clear all

NCT07624487 2026-06-03

A Phase II Study of Aumolertinib Combined With Phased Chemotherapy for EGFR L858R Lung Adenocarcinoma

Phase 2 Not yet recruiting

Adenocarcinoma of Lung

NCT07482605 2026-03-20

Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion

Phase 2 Not yet recruiting

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pleural Effusion, Malignant

NCT07416058 2026-02-17

PHOENIX

Phase 2 Not yet recruiting

Diabetes Mellitus, Insulin-Dependent, 12, Adenocarcinoma of Lung

NCT06818955 2025-02-12

OOTER

Phase 2 Not yet recruiting

Adenocarcinoma of Lung

NCT06483672 2024-07-03

LungBrain001

Phase 2 Not yet recruiting

Adenocarcinoma of Lung, Brain Neoplasms